Klemt Christian

Avg. Two Year Performance

No purchase track record

(9%) Avg. Sale Return

(5%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	5%	(16%)	3%	(11%)	(9%)
Sale Success Rate	3 of 11	1 of 11	4 of 11	1 of 11	0 of 11

Uniqure N.V.

Drugs » Biotechnology

Chief Financial Officer:

Holdings: 164.84K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--